China and its Regions Strengthen Tobacco Control Measures

Regulations by 2FIRSTS.ai
Dec.22.2023
China and its Regions Strengthen Tobacco Control Measures
China Smoke Control Association recently held a smoke control exchange event in Shanghai, aiming to promote a healthy China.

According to a report on December 21 by the Central People's Broadcasting Station website, the China Tobacco Control Association recently held a tobacco control exchange event in Shanghai, involving the mainland, Taiwan, Hong Kong, and Macau regions. During the event, tobacco control workers and academic experts from Shanghai, Hong Kong, and Macau shared their experiences and achievements in tobacco control, with the aim of collectively promoting the construction of a healthy China.

 

The implementation of the "Shanghai Initiative" in tobacco control aims to improve life expectancy. Since the implementation of smoking regulations in public places in Shanghai since 2010, the city's tobacco control efforts have been strengthening social governance, forming a "six-one" model of tobacco control promotion, supervision, and law enforcement. This model includes one system, one mechanism, one guideline, one graphic, one network, and a series of working methods, and has achieved remarkable results.

 

The adult smoking rate in Shanghai has shown a continuous downward trend for 12 consecutive years, with the smoking rate in 2022 reaching a record low of 19.4%. This represents a significant decline of 7.5 percentage points since the implementation of anti-smoking legislation in 2010, and is considerably lower than the national average smoking rate of 24.1%. Moreover, Shanghai has achieved the targets set under the "Healthy China 2030" initiative ahead of schedule. Furthermore, according to the results of the 2021 National Survey on Tobacco Use among Youth, the prevalence of cigarette and e-cigarette use among middle school students in Shanghai is the lowest among all 31 provinces in the country.

 

Over the past decade or so, Shanghai has consistently provided a replicable and scalable "Shanghai model" for tobacco control efforts nationwide and urban governance. The first mainland tobacco control law legislated by the National People's Congress in 2007 has served as a great guiding force and support for the overall process of tobacco control legislation in the country.

 

Hong Kong and Macau also shared their achievements in tobacco control during the event and discussed new strategies to tackle dual challenges. Currently, tobacco control efforts are facing challenges from both new tobacco products and traditional tobacco products. Experts at the conference stated that future tobacco control work will continue to focus on aspects such as smoke-free legislation, smoke-free environments, tobacco monitoring, warning about tobacco hazards, smoking cessation services, smoking-related diseases, youth tobacco control, tobacco taxes and prices, banning tobacco advertising, promotion and sponsorship, as well as e-cigarettes. These efforts aim to promote social governance in tobacco control and contribute to the construction of a healthy China.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
JT Launches Limited-Edition Ploom AURA “Fuchsia Flare” in Advance Sales Starting March 10
JT Launches Limited-Edition Ploom AURA “Fuchsia Flare” in Advance Sales Starting March 10
Japan Tobacco Inc. (JT) began advance sales on March 10 for the fifth limited-edition color of its heated tobacco device “Ploom AURA,” named “Fuchsia Flare.” The product is available through the CLUB JT online shop and Ploom Shops nationwide at a price of JPY 2,980. From March 17, it will also be sold in limited quantities at convenience stores nationwide and selected tobacco retailers.
Mar.10 by 2FIRSTS.ai
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12
Ohio Supreme Court takes up appeal that could define state limits on illegal vape sales enforcement
Ohio Supreme Court takes up appeal that could define state limits on illegal vape sales enforcement
The Ohio Supreme Court has agreed to hear Attorney General Dave Yost’s appeal seeking to revive lawsuits against three Ohio vape retailers. Lower courts dismissed the cases, finding that federal law governs whether vaping products may be marketed and sold.
Mar.06 by 2FIRSTS.ai
Product | Claiming a “first multi-beverage vaporizer” with refillable juice/cocktail water chamber, PEAKBAR launches new device in the U.S.
Product | Claiming a “first multi-beverage vaporizer” with refillable juice/cocktail water chamber, PEAKBAR launches new device in the U.S.
PEAKBAR’s new H2O 40K has begun selling through U.S. online retailers including Vape Sourcing. Marketed as the “world’s first multi-beverage vaporizer,” the device is promoted as allowing users to add liquids such as juice and cocktails into a water chamber for pairing. Publicly listed specifications include 20 ml of e-liquid, a rated 40,000 puffs, 0.5% nicotine, a 1,000 mAh rechargeable battery, and two power modes at 22W and 12W.
Jan.22 by 2FIRSTS.ai
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s National Health Insurance Service (NHIS) has again lost on appeal in its damages lawsuit against KT&G, Philip Morris Korea and BAT Korea, seeking ₩53.3 billion (about $36.244 million).
Jan.15 by 2FIRSTS.ai